[144] Samsara Inc. SEC Filing
Rhea-AI Filing Summary
Samsara Inc. (IOT) Form 144 notice: A proposal to sell 33,331 shares of Class A common stock is reported through Raymond James & Associates, scheduled approximately for 09/09/2025 on the NYSE. The filing lists an aggregate market value of $1,384,236.43 and total shares outstanding of 299,748,928, indicating the portion offered represents a small fraction of outstanding equity. The securities were acquired on 12/10/2024 as an in-kind equity distribution from Andreessen Horowitz; the payment/nature of sale is listed as cash. The filer reports no securities sold in the past three months and includes the standard representation that no undisclosed material adverse information is known.
Positive
- Clear transaction details provided: class, broker, share count, aggregate value, acquisition date, and source (Andreessen Horowitz).
- No recent sales reported: filer states "Nothing to Report" for securities sold during the past three months.
Negative
- None.
Insights
TL;DR: A non-routine transfer by Andreessen Horowitz of 33,331 Class A shares, valued at about $1.38M, is slated for sale via Raymond James.
The filing documents a proposed sale of 33,331 Class A shares on 09/09/2025 through Raymond James & Associates with an aggregate market value of $1,384,236.43. The shares were acquired 12/10/2024 as an in-kind equity distribution from Andreessen Horowitz. No sales in the prior three months are reported. Given the modest size relative to the 299,748,928 shares outstanding, the transaction appears procedural rather than company-changing based on the information provided.
TL;DR: The notice discloses a routine Rule 144 planned sale tied to an in-kind distribution from a VC investor.
The form shows the seller intends to rely on Rule 144 to dispose of shares acquired via an in-kind equity distribution from Andreessen Horowitz. The filing includes the customary signer representation denying possession of undisclosed material adverse information. The document does not identify the seller's role or any special restrictions beyond the Rule 144 notice itself, limiting conclusions about governance implications strictly to disclosure of the planned sale.